Pictet Biotech

Pictet Biotech I dy GBP

  • FE Crown Rating: 3
  • FE Manager Rating:
  • Trustnet Direct 100:
    1year Growth
Pictet Biotech I dy GBP 19.6%
Specialist
12.4%
  (Benchmark)  
0 150+
220
83

FE RISK SCORE

 
1year
3year
1st Quartile
 
 
2nd Quartile
 
 
3rd Quartile
 
 
4th Quartile
 
 

FUND RANKING

Currency: GBP
Mid: 630.24
Change: -6.91
Yield: n/a

PRICE

Initial Charges: 0.00%
Annual Mgt. Charge: 0.80%
Ongoing Charges Figure: 1.21%
ISA: SIPP:

CHARGES

Advertisement

2a
PAST PERFORMANCE: FUND VS SECTOR
1b
FUND MANAGER CLOSE
    Lydia Haueter 26-May-2016 to Present
    Manager Picture

    Lydia Haueter

    +24.0%

    Fund annualised total return over 1.2 years

    Tazio Storni 26-May-2016 to Present
    Manager Picture

    Tazio Storni

    +24.0%

    Fund annualised total return over 1.2 years

    Manager Picture

    Grégoire Biollaz

    +29.9%

    Fund annualised total return over 0.8 years

    Manager Picture

    Nathalie Flury

    +29.9%

    Fund annualised total return over 0.8 years

    Manager Picture

    Michael Sjostrom

    n/a

    Fund annualised total return over 10.0 years

    Manager biography not available

    Tazio Storni joined Pictet Asset Management in October 2014 as a Senior Investment Manager in the Sector & Theme Funds team. He began hi...

    Manager biography not available

    FULL DETAILS
  • +24.0%

    Fund annualised total return over 1.2 years

    Lydia Haueter - Primary Manager Managed this fund 26-May-2016 to Present

    +24.0%

    Fund annualised total return over 1.2 years

    Tazio Storni - Primary Manager Managed this fund 26-May-2016 to Present

    +29.9%

    Fund annualised total return over 0.8 years

    Grégoire Biollaz Managed this fund 26-May-2016 to 23-Mar-2017

    +29.9%

    Fund annualised total return over 0.8 years

    Nathalie Flury Managed this fund 26-May-2016 to 23-Mar-2017

    n/a

    Fund annualised total return over 10.0 years

    Michael Sjostrom Managed this fund 01-Jan-2000 to 25-May-2016

    +8.5%

    Fund annualised total return over 1.3 years

    Carmen Tang Managed this fund 16-Dec-2008 to 31-Mar-2010
SUMMARY DETAILS
 
4d
FUND OBJECTIVES & COMPANY INFO
The sub-fund seeks capital growth by investing at least two-thirds of its total assets in the shares of particularly innovative companies operating in medical biotechnology. The investment universe is not restricted to a specific geographical zone. However, given the particularly innovative nature of the pharmaceutical industry in North America and Europe, the vast majority of investments will be made in this zone.
Investment Objectives
The sub-fund seeks capital growth by investing at least two-thirds of its total assets in the shares of particularly innovative companies operating in medical biotechnology. The investment universe is not restricted to a specific geographical zone. However, given the particularly innovative nature of the pharmaceutical industry in North America and Europe, the vast majority of investments will be made in this zone.

Contact Details
15, Avenue J.F. Kennedy, Luxembourg, L-1855
MN (Main Number)


MORE & FULL COMPANY INFORMATION
5e
PORTFOLIO BREAKDOWN & HISTORY
  Name Total% Rank (Prev)
 
CELGENE CORP
9.50 1 1
 
REGENERON PHARMACEUT...
6.40 2 2
 
BIOGEN INC
5.50 3 5
  Name Total% Rank (Prev)
 
Health Care
56.00 1 1
 
Pharmaceuticals
22.30 2 2
 
Technology
13.70 3 3
 NameTotal%Rank(Prev)
 
US Equities
92.30 1 1
 
UK Equities
3.50 2 2
 
Spanish Equities
1.20 3 3
Estimated from fund's sector average
 NameTotal%Rank(Prev)
 
USA
92.30 1 1
 
UK
3.50 2 2
 
Spain
1.20 3 3
Top 10 Holdings
 NameTotal%Rank(Prev)
 
CELGENE CORP
9.50 1 1
 
REGENERON PHARMACEUT...
6.40 2 2
 
BIOGEN INC
5.50 3 5
 
AMGEN INC
5.30 4 4
 
VERTEX PHARMACEUTICA...
5.10 5 3
 
GILEAD SCIENCES INC
4.30 6 7
 
INCYTE CORP
4.20 7 6
 
ALEXION PHARMACEUTIC...
3.80 8 9
 
BIOMARIN PHARMACEUTI...
3.50 9 8
 
JAZZ PHARMACEUTICALS...
2.50 10 -
TOTAL50.10  
Top 10 Sectors
 SectorTotal%Rank(Prev)
 
Health Care
56.00 1 1
 
Pharmaceuticals
22.30 2 2
 
Technology
13.70 3 3
 
Services
7.30 4 4
 
Money Market
0.70 5 5
    
    
    
    
    
TOTAL100.00  
Top 10 Assets
 AssetTotal%Rank(Prev)
 
US Equities
92.301 1
 
UK Equities
3.502 2
 
Spanish Equities
1.203 3
 
Irish Equities
1.104 4
 
Money Market
0.705 6
 
Belgian Equities
0.606 5
 
Dutch Equities
0.407 7
 
Swiss Equities
0.208 8
    
    
TOTAL100.00  
Estimated from fund's sector average
Top 10 Regions
 RegionsTotal%Rank(Prev)
 
USA
92.301 1
 
UK
3.502 2
 
Spain
1.203 3
 
Ireland
1.104 4
 
Money Market
0.705 6
 
Belgium
0.606 5
 
Netherlands
0.407 7
 
Switzerland
0.208 8
    
    
TOTAL100.00  
SHOW ALL
7f 5e
KEY STATISTICS
Fund Type: n/a Minimum Investment: £100
Launched: 10-Sep-2009 Minimum Regular Investment: £20
Fund size: £1,101.7m / $1,436.4m (24-Jul-17) Dealing Charge: £10 or £6 for frequent traders
Dealing Frequency: n/a Initial Charge: 0.00%
Dealing Time: n/a Annual management charge: 0.80%
Price Times: 15:00 Daily Note to charges: Initial Charges: max.; Annual ...
Fund Type: n/a
Launched: 10-Sep-2009
Fund size: £1,101.7m / $1,436.4m (24-Jul-17)
Dealing Frequency: n/a
Dealing Time: n/a
Price Times: 15:00 Daily
Trustee / Depositary: Pictet & Cie (Europe) S.A.
Registrar: FundPartner Solutions (Europe) S.A.
Minimum Investment: £100
Minimum Regular Investment: £20
Dealing Charge £10 or £6 for frequent traders ?
Initial Charge: 0.00%
Annual management charge: 0.80%
Note to charges: Initial Charges: max.; Annual Management Charges: max.2.9%;
Dividend Policy: Dec 03 (Final)
Multi-manager: n/a
Index: MSCI World
ISA: ISA Wrapper
Savings plan: Savings Plan
CAT Standard: CAT Standard
ISIN: LU0448836352
Sedol: B554RF5
SHOW ALL
8g
RATIOS
1year 3year
Volatility 20.46 23.17
Alpha 28.71 14.55
Beta 0.02 0.61
Sharpe 1.14 0.56
InfoRatio 0.47 0.39
RSquared 0.00 0.07
QUARTILES KEY:
1st 2nd 3rd 4th

Fund Filter

Find the best,
fast, from our
huge fund range.

JUST A FEW CLICKS

Trustnet Direct
Top 100 Funds

THE TRUSTNET DIRECT 100

5 big reasons
to open an
account

#5
Straightforward
low charges, that
stay low.

FIND OUT MORE

SIPP: Self Invested Personal Pension

Get a clear view
of the advantages

A GIFT FROM THE GOVERNMENT
 
CLOSE